BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34696771)

  • 21. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB
    Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma.
    Jin C; Zhao J; Zhang ZP; Wu M; Li J; Xiao GL; Liu B; Liao YX; Liu JP
    J Neurooncol; 2020 Jul; 148(3):529-543. PubMed ID: 32472311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
    Gai SY; Yuan ZH
    Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma.
    Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q
    Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA HOXB13-AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma.
    Xiong Y; Kuang W; Lu S; Guo H; Wu M; Ye M; Wu L
    Cancer Med; 2018 Sep; 7(9):4718-4728. PubMed ID: 30105866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
    Dong H; Cao W; Xue J
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
    Chen Y; Zhao F; Cui D; Jiang R; Chen J; Huang Q; Shi J
    Int J Cancer; 2018 Jun; 142(11):2313-2322. PubMed ID: 29341117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
    Yan J; Jia Y; Chen H; Chen W; Zhou X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of long non-coding RNA VIM-AS1 inhibits glioma cell proliferation and migration, and increases the cell apoptosis via modulation of WEE1 targeted by miR-105-5p.
    Suo ST; Gong P; Peng XJ; Niu D; Guo YT
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6834-6847. PubMed ID: 32633376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TMEM44-AS1 promotes esophageal squamous cell carcinoma progression by regulating the IGF2BP2-GPX4 axis in modulating ferroptosis.
    Yang R; Wan J; Ma L; Zhou F; Yang Z; Li Z; Zhang M; Ming L
    Cell Death Discov; 2023 Dec; 9(1):431. PubMed ID: 38040698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
    Gu N; Wang X; Di Z; Xiong J; Ma Y; Yan Y; Qian Y; Zhang Q; Yu J
    Aging (Albany NY); 2019 Nov; 11(22):10266-10283. PubMed ID: 31770107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan-Gelatin-EGCG Nanoparticle-Meditated LncRNA TMEM44-AS1 Silencing to Activate the P53 Signaling Pathway for the Synergistic Reversal of 5-FU Resistance in Gastric Cancer.
    Zhou M; Dong J; Huang J; Ye W; Zheng Z; Huang K; Pan Y; Cen J; Liang Y; Shu G; Ye S; Lu X; Zhang J
    Adv Sci (Weinh); 2022 Aug; 9(22):e2105077. PubMed ID: 35717675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.